Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
2014 · New England Journal of Medicine · 1,875 citations
https://doi.org/10.1056/nejmoa1409312
M
Mitchell W. Krucoff
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
513
Papers
39.3K
Citations
78
h-index
246
i10-index
Mitchell W. Krucoff is an academic researcher from Duke University. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Acute Myocardial Infarction Research & Cardiac Imaging and Diagnostics. The author has an h-index of 78, co-authored 437 publications.
Papers by this author
worksOutcomes of Anatomical versus Functional Testing for Coronary Artery Disease
2015 · New England Journal of Medicine · 1,466 citations
https://doi.org/10.1056/nejmoa1415516
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
2019 · New England Journal of Medicine · 970 citations
https://doi.org/10.1056/nejmoa1908419
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
2018 · Circulation · 894 citations
https://doi.org/10.1161/circulationaha.117.029289
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
2019 · European Heart Journal · 549 citations
https://doi.org/10.1093/eurheartj/ehz372
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
2016 · Journal of the American College of Cardiology · 537 citations
https://doi.org/10.1016/j.jacc.2016.02.064
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat